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Abstract
The growth cone, the tip of the emerging neurite, plays a crucial role in establishing the wiring of the developing nervous
system. We performed an extensive proteomic analysis of axonal growth cones isolated from the brains of fetal Sprague-
Dawley rats. Approximately 2000 proteins were identified at $99% confidence level. Using informatics, including functional
annotation cluster and KEGG pathway analysis, we found great diversity of proteins involved in axonal pathfinding,
cytoskeletal remodeling, vesicular traffic and carbohydrate metabolism, as expected. We also found a large and complex
array of proteins involved in translation, protein folding, posttranslational processing, and proteasome/ubiquitination-
dependent degradation. Immunofluorescence studies performed on hippocampal neurons in culture confirmed the
presence in the axonal growth cone of proteins representative of these processes. These analyses also provide evidence for
rough endoplasmic reticulum and reveal a reticular structure equipped with Golgi-like functions in the axonal growth cone.
Furthermore, Western blot revealed the growth cone enrichment, relative to fetal brain homogenate, of some of the
proteins involved in protein synthesis, folding and catabolism. Our study provides a resource for further research and
amplifies the relatively recently developed concept that the axonal growth cone is equipped with proteins capable of
performing a highly diverse range of functions.
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Introduction
The nerve growth cone is the enlarged leading edge of the
growing neurite. It is the primary site of neurite formation, which
involves plasmalemmal expansion as well as cytoskeletal assembly
[1,2,3]. The growth cone advances through tissue by amoeboid
movement while probing the microenvironment with its filopodia
for molecular cues. Axonal growth cones, on which this report is
focused, travel considerable distances through the central nervous
system or peripheral tissues to reach their target cell(s) for
synaptogenesis. Pathfinding is accomplished by detection of, and
reaction to, multiple substrate-bound and soluble molecular
signals, such as cell surface and extracellular matrix molecules,
growth factors, growth cone attractants, and growth cone
repellents [4,5]. Once the axonal growth cone has reached and
recognized an appropriate target cell synaptogenesis ensues.
During this process the growth cone is replaced by a presynaptic
nerve terminal. Thus, the nerve growth cone is a developmentally
regulated structure specialized for neurite assembly, amoeboid
movement, detection of growth and guidance signals, and target
cell recognition for synaptogenesis. As such it plays a key role in
neuronal network formation and modulation during development
and plasticity. As our understanding of specific growth cone
functions has increased so has the evidence for their complexity.
Nevertheless, the axonal growth cone has been viewed tradition-
ally as wholly dependent on the parent neuron’s perikaryon for the
supply of almost all macromolecular constituents.
Axonal growth cones can be isolated by subcellular fraction-
ation from developing rodent brain with reasonable purity [6,7].
Criteria for the identity and purity of the fraction include (a)
electron microscopic analysis, (b) co-purification of growth cones
micro-dissected from cultures, (c) the enrichment of ‘‘marker’’
molecules, such as growth-associated protein 43 (Gap43), known
to be abundant in axonal growth cones, and (d) depletion of non-
axonal proteins, such as dendritic and glial markers [6,7,8]. Thus,
this ‘‘growth cone particle’’ (GCP) fraction can be used to
determine the axonal growth cone’s proteome. This was done
successfully by Nozumi and co-workers [9], who validated the
approach and described over 900 GCP proteins. They used the
GCP preparation developed in our laboratory [7] and verified the
presence of 131 GCP proteins in axonal growth cones of cultured
cortical neurons by immunofluorescence microscopy. A major
goal of their study was to identify potential new growth cone
markers. Using a somewhat different approach and advanced
instrumentation we identified over 2000 proteins at very high
confidence level ($99%) and subjected the identified species to
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31858extensive, broad-based informatics analysis. While our results are
largely consistent with the data from the Nozumi et al. [9] study
they reveal the presence in axonal growth cones of a highly
complex machinery of biological processes. (Proteins are referred
to by the official names of the genes encoding them. A list of all
proteins and official gene names is provided in Table S1.)
Results
1. Limitations and Validation of the Approach
GCPs are derived from whole forebrain and, thus, from a great
variety of neuron types. Therefore, proteins identified in the GCP
fraction may come from all or only from subsets of growth cones in
the brain. However, the proteomic analysis favors the proteins
shared by all growth cones because they are domineering. GCPs
are recovered from a discontinuous density gradient as a band that
also contains a large amount of cytosolic protein (essentially fetal
brain high-speed supernatant [7]), and the GCPs cannot be
washed by re-suspension and pelleting without disruption. To
avoid GCP contamination with cytosolic proteins from other
regions of the neuron or from other cells we plated GCPs on the
physiologic substrate laminin, rinsed off soluble components and
then harvested the GCP proteins. This procedure allowed us to
remove the bulk of soluble proteins (and to isolate adhesive
structures for separate analysis; Estrada et al., in preparation). To
identify potentially contaminating cytosolic proteins we performed
proteomic analysis of the fetal brain high-speed supernatant. In
addition, we generated proteomic profiles from the laminin plating
substrate (without GCPs), another potential contributor of non-
GCP proteins. These two data sets represent ‘‘background’’
proteins.
Mass spectra were analyzed with Scaffold software, using the
99% confidence limit (minimum number peptides, 2; minimum
confidence level for peptide identification, 95%). This identified a
total of 2130 proteins in the plated GCP fraction (based on 139,158
spectra; Table S2). Spectral counts per protein reached from small
numbers into the thousands. The number of identifying spectra
per protein was used as a semi-quantitative measure of protein
abundance (the limitations of this approach are considered in
Discussion). Proteins whose spectral counts in the GCP preparation
were equal or lower than in the background fractions were excluded
from further analysis. This was done as follows: Spectral frequencies
of proteins found in the laminin preparation were subtracted from
those of the respective proteins in the GCP fraction. To determine
how much high-speed supernatant protein to subtract as back-
ground we chose two test proteins, serum albumin (Alb) and a-
fetoprotein (Afp), which are not growth cone components but
present in fetal brain high-speed supernatant. We calculated the
multipliers of their spectral numbers that equaled them to those of
the GCP contamination levels so that, when subtracted, their
spectral numbers in the GCP preparation would total zero. The two
multipliers were 0.29 and 0.34 for Alb and Afp, respectively. We
used the mean of these values (0.315) as a multiplier for all spectral
counts in the high-speed supernatant and subtracted these numbers
from the respective GCP spectral counts. Thus, the frequencies of
identifying spectra of net GCP proteins were the result of
subtracting the entire background [laminin fraction without
GCPs+0.3156(high-speed supernatant fraction)]. This procedure
almost completely eliminated from the GCP proteome not only
Afp and Alb, but also 3 other serum proteins (transferrin, a2-
macroglobulin and IgG subunits). This result validated the
approach, at least within the limitation that contaminating proteins
would be present in similar proportions. The background
subtraction reduced the net GCP count by 313 to 1981 proteins.
Uploading the data into the DAVID informatics tool (DAVID
Bioinformatics Resources 6.7; [10,11,12]) resulted in 1817
DAVID identifications (164 gi accession numbers, or ,10%,
were not recognized by DAVID). These 1817 GCP proteins
formed the basis for all subsequent informatics analyses, together
with their net (after background subtraction) spectral frequencies.
These data are listed in Table S2. Protein names and accession
numbers are listed as provided by Scaffold software. In a few cases,
accession numbers refer to mouse or human, rather than rat,
proteins. It should be noted that the spectral abundance of some
proteins, especially those associated with adhesions (e.g., integrins;
myristoylated alanine-rich C-kinase substrate), was much lower
than expected. This likely is the result of incomplete solubilization
of the laminin-adherent adhesion complexes.
Figure 1 shows the distribution of selected assigned spectra
between net GCPs (blue) and background (green) as % of total
spectra detected in the crude GCP fraction, prior to background
subtraction. The total number of spectra detected is shown on the
right. Axonal growth cone markers, such as neuropilin 1 (Nrp1),
Gap43 and exocyst component 8 (Exoc8) are essentially confined
to the growth cone preparation. The axonal cytoskeletal
components, microtubule-associated proteins tau (Mapt) and 1b
(Map1b), also were detected primarily in the growth cone
preparation, whereas Map2b, present in emerging (but not
mature) axons and in dendrites [13,14,15], was about equally
abundant in growth cones and background. The solute carrier
family 1 (high-affinity glutamate transporter), member 3 (Slc1a3;
also known as GLAST-1), present in both neurons and glia,
was detected primarily in GCPs whereas member 2 (Slc1a2;
also known as GLT-1), present in glia only, was confined to
background [16]. Potential nuclear contaminants, an RNA
polymerase II complex component (Rtf1) and APEX nuclease
(Apex1), also were detected in the background only, as were the
serum proteins Afp, Alb and transferrin (Tf), as mentioned above.
Likewise, histones H2B (Hist1h2bl) and H4 were present in
background but not in the net GCP preparation (Table S2).
Except for Hist3h2ba no histones were seen in net GCPs, and
nuclear lamins were not detected. These results strongly indicate
that the growth cone preparation analyzed is primarily axonal and
not significantly contaminated with extraneous proteins.
2. Overall Evaluation of the Proteome
To obtain an initial reading of the growth cone proteome we
surveyed (a) the most abundant spectra and (b) the enrichment of
functional annotations of cellular components in the net GCP
preparation. All proteins with spectral frequencies of $400, the 43
most abundant proteins, are shown in Figure 2. They are
presented in 8 functional groups. The % values indicate for each
group the cumulative frequency of spectra relative to all spectra
detected. As expected, cytoskeletal components and associated
proteins were predominant and the 8 proteins in the group
contributed 16.5% of all spectra. Among them was the
microtubule motor dynein (Dync1h1) as the 6
th most abundant
protein detected. This is consistent with the known importance of
vesicular transport to the axonal growth cone. Collapsin response
mediator proteins (CRMPs/dihydropyrimidinase-like proteins),
involved in the regulation of microtubule function, cell polarity
and growth cone repulsion [17], also form a highly prominent
group of proteins. Metabolic proteins were abundant, as expected.
Surprisingly, however, one of these was fatty acid synthase (Fasn).
The vesicle-traffic-associated proteins valosin-containing protein
(Vcp) and clathrin (Cltc, heavy chain) were heavily represented as
well. Surprising, however, was the fact that 11 (or 25%) of the most
abundant proteins were involved in protein folding, totaling 6.3%
Proteome of the Axonal Growth Cone
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spectra identifying 3 proteins involved in ubiquitin/proteasome-
dependent protein catabolism and 2 translation elongation factors.
Prominent proteins involved in cell regulatory functions included
two 14-3-3 proteins (Ywhaz and Ywhae) and two Rab GDP
dissociation inhibitors (Gdi1 and Gdi2), as well as two nuclear
importins (Ipo5 and Kpnb1). Spectra of the Ig superfamily cell
adhesion molecule Ncam1 also were detected with high frequency.
A complementary approach to the overall evaluation of the
growth cone proteome is functional annotation using GO (Gene
Ontology) Terms and the DAVID informatics tool. GO Terms fall
into different categories, including ‘‘Cellular Component’’. This
category is particularly useful for describing functions of cellular
organelles. Figure 3 shows examples of the most enriched cellular
component GO Terms in the net growth cone proteome, grouped
functionally. ‘‘Fold enrichment’’ refers not to relative protein
abundance but to the number of relevant protein species present
relative to random protein expression. ‘‘% count’’ indicates the
percentage of protein species associated with each GO Term
relative to the total number of protein species in the net GCP
proteome. The results indicate the expected significant enrichment
of GO Terms known to be associated with the axonal growth cone,
such as ‘‘cytoskeleton’’ and ‘‘vesicular traffic’’. Surprising, however,
was the high enrichment of GO Term components associated with
protein synthesis, processing (including folding) and degradation.
The relatively simple analyses just presented indicate the
expected enrichment of growth cone markers (versus contami-
nants) and of other proteins associated with well-known growth
cone functions in the GCP proteome. In addition, however, these
analyses point to the prominent presence of highly developed
machinery for protein synthesis, processing and degradation.
These observations are explored in further detail below.
3. Functional Annotation Clusters (Biological Processes)
and KEGG Pathways
GO Terms for biological processes and KEGG Pathways
(Kyoto Encyclopedia of Genes and Genomes) describe ordered
multi-step, multi-molecular operations in the cell. Similarly,
annotation clusters, as provided by DAVID, describe functionally
linked groups of biological-process GO Terms. Figure 4 illustrates
the 13 most enriched annotation clusters (in terms of the number
of protein species represented, relative to random expression of all
genes in the genome). They are numbered 1–13, and highlighted
by colored boxes. The enrichment score is indicated for each
cluster; the fold enrichment (burgundy red) and % count (number
of included protein species relative to total number of protein
species present; blue) are shown for sample GO Terms in the bar
graphs. Benjamini coefficients are shown for each GO Term on
the far right. At ,0.05 all values are significant, with most of them
highly significant at ,0.001. Some of the GO Terms that were
strongly represented in the growth cone proteome were not
included in any DAVID annotation clusters. We grouped these
functionally and listed them also (A–E). The bar graph conveys the
enrichment and the number of protein species participating in a
specific biological process for a broad range of growth cone
functions. Particularly striking are the high enrichment (.3-fold)
of several biological processes and the large number of protein
species (.7% of total number) participating in intracellular/
vesicle-mediated transport (Annot. Cluster 1).
Most of the high-scoring annotation clusters and Groups C and D
shown in Figure 4 wereexpected. However, Group A includes greatly
enriched GO Terms involving Golgi functions, Annotation Cluster 3
deals with ubiquitin- and proteasome-dependent protein catabolism,
Annotation Cluster 7 and Group B show high enrichment of
components needed for protein synthesis (we detected 35 ribosomal
proteins), and Annotation Cluster 12 is focused on protein complex
assembly (almostall with highlysignificant Benjamini scores ,0.001).
Also of interest is the great enrichment of cellular responses to
o x i d a t i v es t r e s s( G r o u pE ) .T a b l e1s u m m a r i z e st h ed a t af r o mt h e
opposite end of the annotation cluster spectrum, clusters with very
low ‘‘enrichment’’ scores and with GO Terms that are ‘‘de-
enriched’’. These clusters include, among obviously irrelevant GO
Terms, such terms as ‘‘Regulation of transcription’’, ‘‘Chromatin
(dis)assembly’’, and ‘‘Regulation of cell proliferation’’. In other words,
Figure 1. Relative distribution of assigned spectra between growth cones (blue) and background (green). Identified proteins (listed by
gene name) are grouped as ‘‘markers’’ of axonal (A) growth cones, axonal or dendritic (D) cytoskeleton, neurons (N), glia (G), the nucleus or serum.
Total numbers of identifying spectra detected for each protein are indicated on the right.
doi:10.1371/journal.pone.0031858.g001
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processes in the growth cone proteome.
A complementary analysis of biological processes was per-
formed with a search for KEGG pathways that are significantly
enriched in the growth cone proteome. Table 2 lists the 20
pathways represented with the highest statistical significance. Four
of these pathways (superscripted a-d) are represented by many
components but lack key identifying elements: the Fcc receptor (a);
claudins and occludins (b); the insulin receptor (c); and ErbB (d).
Therefore, they should be considered only to the extent that they
overlap with other pathways operating in the growth cone
(signaling that targets the cytoskeleton for a; cell junction/cell
adhesion-related processes for b; growth factor signaling for c and
d). The identification of the DNA replication pathway results
mainly from the presence of mini-chromosome maintenance
(Mcm) proteins 2–7 (components of the prereplication complex)
and proliferating cell nuclear antigen (Pcna). This finding is
surprising, but these proteins have been observed in the
extranuclear cytoplasm after DNA replication [18,19,20] (for
immunofluorescence data, see below). Among the other KEGG
pathways, Proteasome, Aminoacyl-tRNA Biosynthesis, Ubiquitin-
Mediated Proteolysis, and Terpenoid Backbone Biosynthesis are of
Figure 2. The 43 highest-ranked proteins based on identifying spectra ($400) detected in the net GCP preparation. The proteins are
grouped functionally. CRMP, collapsing response mediator proteins. Percent values indicate the cumulative number of spectra identifying the
proteins shown in each group relative to the total number of spectra detected in growth cones.
doi:10.1371/journal.pone.0031858.g002
Proteome of the Axonal Growth Cone
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31858particular interest because they confirm the significant enrichment
of pathways involved in protein synthesis and degradation, as well
as in the synthesis of cholesterol and the geranyl/farnesyl
modifications of membrane proteins.
Figure 5 presents a more comprehensive view of known KEGG
pathways that are significantly enriched in, or absent from, the
growth cone proteome, listed by major category and subcategory
(see KEGG Pathway Database). The numbers following the titles
of each subcategory indicate the number of pathways detected in
growth cones/total number of identified pathways in mammals.
KEGG pathway subcategories that were detected in growth cones
are highlighted by shading. The bar graph shows the average
growth cone enrichment for each subcategory (green). Blue bars
indicate enrichment of specific KEGG pathways, while ochre bars
indicate the number of protein species of the pathway represented
in growth cones. As in the previous analysis, there are both
expected (typifying) and non-typifying results. Strong representa-
tion of carbohydrate (1.1), nucleotide (1.4) and amino acid (1.5,
1.6) metabolism, of several cellular processes (4.1, 4.2, 4.4), of
nervous system-specific pathways (5.6) and axon guidance (5.8
Development) was expected (numbers refer to the KEGG pathway
categories in Fig. 5). That none of the lipid metabolism pathways
(1.3) were found to be enriched is surprising in view of the facts
that extensive lipid re-modeling occurs at the growth cone [21],
and that fatty acid synthase (Fasn) is one of the most abundant
growth cone proteins (Fig. 2). One of the six defined Replication
and Repair pathways was enriched (see also Table 2), but none of
the Cell Growth and Death pathways (4.3) were found to be
prominently represented.
Of special interest is the finding that two of the three enriched
amino acid metabolism pathways (1.5, 1.6) involve cysteine,
methionine and glutathione. This parallels the previous observa-
tion (Fig. 4, E) that the biological process GO Terms ‘‘Cellular
response to hydrogen peroxide’’ and ‘‘Cellular response to
oxidative stress’’ are highly enriched in the growth cone. The
remarkable enrichment of the Terpenoid Backbone Biosynthesis
pathway (1.9), the two Translation pathways (2.2) and, especially,
3 of the 6 Folding, Sorting and Degradation pathways (2.3) point
again to the significance of protein synthesis, processing and
degradation in the growth cone.
4. Protein Abundance by GO Term
The analyses presented above are focused on the diversity of
protein species present in the growth cone. Here we address the
Figure 3. Functional annotation (‘‘Cellular Component’’) analysis of the growth cone proteome. GO Terms are listed in functional
groups. Enrichment values (relative to random expression) are shown in red; % count (grey) indicates the number of protein species associated with
each GO Term relative to the total number of protein species in net GCPs. For the enrichment values, p,0.01; Benjamini scores ,0.05.
doi:10.1371/journal.pone.0031858.g003
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31858Figure 4. Functional annotation clusters (‘‘Biological Process’’, BP) in the growth cone proteome (DAVID). The 13 most enriched
clusters and characteristic examples of their GO Terms are shown, together with their enrichment scores, in the colored boxes. Bars show GO Term
enrichment (burgundy) and % count (number of included protein species relative to total number of protein species in GCPs; blue). Benjamini scores
are shown on the far right. The DAVID annotation cluster analysis left out a number of highly enriched GO Terms that were grouped functionally (A–
E) and are listed also.
doi:10.1371/journal.pone.0031858.g004
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clusters, as reflected semi-quantitatively in the relative number of
identifying spectra. Figures 6, 7 and 8 relate the number of
detected spectra to specific GO Terms, i.e., those that are typically
prominent in the neuronal perikaryon (Figs. 7, 8) and, for
comparison, those characteristic of growth cones (Fig. 6).
Figure 6A illustrates the most abundant protein-identifying
spectra under the GO Terms ‘‘Growth cone‘‘ (cytoplasmic
component) and ‘‘Axon Guidance’’ (biological process). Spectral
numbers for the ‘‘Growth Cone’’ proteins reach into the hundreds
and thousands. Those involved in ‘‘Axon Guidance’’ were
detected much less frequently, as would be expected, because
many of these proteins are receptors or regulatory molecules that
are present only on growth cone subsets and/or are generally not
as abundant as, e.g., structural proteins. Figures 6B–D show the
proteins with the highest spectral counts that are involved in
cytoskeletal dynamics, vesicle targeting and fusion, and energy
metabolism. Throughout, the proteins listed were detected with
high frequency. The spectral frequencies shown in Figure 6
provide points of reference for the data shown in Figures 7 and 8.
Figure 7 illustrates spectral frequencies for GO Terms related to
translation (A), ER-to-Golgi vesicle traffic (B), protein folding (C),
and ubiquitination and protein catabolism (D). Particularly striking
is the abundance of certain elongation factors, valosin-containing
protein (Vcp, a transitional endoplasmic reticulum ATPase),
several species involved in protein folding, and proteasomal
proteins.
Two other, somewhat unexpected biological-process GO Terms
were enriched and robustly represented in axonal growth cones by
multiple proteins identified with large numbers of spectra. These
were ‘‘Cellular Response to Oxidative Stress’’ and ‘‘Terpenoid
and Sterol Biosynthetic Process’’ (Fig. 8). These observations are
consistent with the annotation cluster and KEGG pathway
analyses. The robust number of identifying spectra indicates that
these proteins are not contaminants but prominent elements of
growth cone function.
Overall, linking the frequency of identifying spectra to
annotation analysis signals the robust presence in axonal growth
cones of the complete machinery of protein synthesis, folding,
post-translational processing and proteasomal degradation. Fur-
thermore these growth cones are enriched in proteins involved in
the response to oxidative stress.
5. Western Blot and Immunolocalization of Selected
Proteins
To support the proteomic results with independent evidence we
performed Western blot and immunolocalization analyses of
proteins representative of the non-typifying functional categories
of the growth cone. Western blots were carried out with fetal brain
homogenate, its low-speed supernatant (LSS) and GCPs (derived
from the LSS). The Western blots allow for semi-quantitative
comparison of protein abundance across the fractions. To monitor
gel loading and growth cone enrichment we probed blots of the
three fractions (40 mg protein/lane; experiments performed in
triplicate) for the cytosolic marker lactate dehydrogenase (Ldh) and
the growth cone marker Gap43. Without exception Ldh seemed
unevenly distributed, peaking in LSS (Figs. 9A and C), a result that
was also obtained with antibody to another cytosolic metabolic
enzyme, glyceraldehydes-3-phosphate dehydrogenase (Gapdh;
data not shown). Even though the apparent differences were not
Table 1. Excluded Annotation Clusters* and Sample GO Terms (BP FAT).
Cluster # Cluster Subject Enrichment Score Prot. Count Fold Change
286 Reproduction 0 - -
Sample GO Term Gamete generation - 20 0.62
285** Transcription 0 - -
Sample GO Term Regulation of transcription - 72 0.45
279 Urogenital system 0.01 - -
Sample GO Term Urogenital system development - 10 0.65
268** Nucleus 0.02 - -
Sample GO Term Chromatin (dis)assembly - 7 0.72
264 Limb development 0.02 - -
Sample GO Term Limb morphogenesis - 6 0.64
263** Cell proliferation 0.02 - -
Sample GO Term Regulation of cell proliferation -5 3 0 . 8
261 Immune response 0.03 - -
Sample GO Term Regulation of leukocyte activation - 11 0.69
256 Immune/inflammatory response 0.05 - -
Sample GO Term Inflammatory response -1 3 0 . 6
251 Meiosis 0.06 - -
Sample GO Term Meiosis -5 0 . 8
249 Sensory perception 0.07 - -
Sample GO Term Sensory perception - 18 0.12
*) Ten representative examples of the 50 least enriched (actually de-enriched) annotation clusters in the growth cone proteome (total number of annotation clusters
identified, 290).
**) Involve key nuclear processes.
doi:10.1371/journal.pone.0031858.t001
Proteome of the Axonal Growth Cone
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31858significant statistically for n=3, our observations indicated that
these enzymes were not optimal as loading controls for this
analysis. Gap43 was highly enriched in GCPs relative to
homogenate in all experiments regardless of whether the numbers
were based on protein loaded (constant) or the level of Ldh
immunoreactivity (enrichment622.766.3 versus 20.664.4, re-
spectively; averages 6 s.e.m; n=3; Fig. 9A, C). Therefore, we
show the data in Figure 9C with each antigen normalized to H
levels and not to Ldh immunoreactivity (though results were
similar). Our results indicated that protein disulfide isomerase
(Pdia6), proteasome a subunits (Psma), and proteasome activator
complex, subunit 3 (Psme3) were present but not enriched in
GCPs relative to brain homogenate. However, some proteins
involved in protein translation (eukaryotic elongation factor
Eef1a1), folding (heat shock protein Hsp90ab1) and ubiquitin-
dependent degradation (ubiquitin-like modifier-activating enzyme
1, Uba1), were significantly enriched in GCPs (Fig. 9A, C).
We localized sample proteins for each of the non-typifying
functional categories by immunofluorescence in hippocampal
pyramidal neurons sprouting in culture. These cultures, grown for
1–2 days, had been prepared from fetal brain at the same
developmental age as the GCP fraction and, therefore, were
comparable. Western blots to ascertain antibody specificity are
shown in Figures 9A and B. Figure 10 illustrates the cellular
location of elongation factor Eef1a1, of 40 S ribosomal protein S3
(Rps3), and of an endoplasmic-reticulum (ER) transmembrane
protein, dolichyl-diphosphooligosaccharide protein glycosyltrans-
ferase subunit 1 (Rpn1; also known as ribophorin). Low-power
images for Rps3 and Rpn1 ascertain the presence of immunore-
activity in axonal growth cones. The high-power images illustrate
antigen distribution in greater detail (co-labeling with fluorescent
phalloidin reveals filamentous actin). The three antigens of interest
are non-homogeneously distributed. This is particularly evident for
Rps3 and Rpn1, whose reactivity forms a reticulum of elongated,
branching structures. Figure 11 illustrates presence and distribu-
tion of protein disulfide isomerase Pdia6 and heat shock protein
Hsp90ab1 in axonal growth cones and throughout the hippocam-
pal neuron. Pdia6, a rough-ER luminal component, occurs in the
form of reticular structures, while the cytosolic Hsp90ab1 is more
evenly distributed throughout the growth cone. Immunolocaliza-
tion of the Golgi components a-mannosidase II (Man2a1),
localized in cis/medial Golgi [22,23], Golgi phosphoprotein 3
(Golph3, also known as GMx33), a cytosolic protein of the trans
face of the Golgi matrix, and trans-Golgi network protein (Tgoln1;
also known as TGN38), an integral membrane protein of the trans
Golgi [24,25], are illustrated in Figure 12. [The antibody to
Man2a1 does not work in Western blots; specificity of the same
anti-Golph3 (a single band of about 35 kDa) antibody was shown
in [24]]. Immunoreactivity of the three Golgi components is
evident in the axonal growth cones, as is the labeling of reticular
patterns, especially for Golph3 and Tgoln1. However, organiza-
tion of the label in Golgi-like stacks was not seen. Immunolocal-
ization of proteins involved in protein catabolism (proteasome a
subunits labeled with a pan-Psma antibody; Psme3 and Uba1) are
shown in Figure 13. The low-power micrograph demonstrates
presence of Psma in the axon and its growth cone, as well as in all
other regions of the developing neuron. The labeling pattern
observed at high magnification is punctate and, sometimes, forms
larger clusters. Psme3 immunofluorescence is punctate as well and,
together with Uba1, reaches into the filopodia.
Table 2. KEGG Pathways in Growth Cones.
Term Protein Count % Fold Enrichm. P-value Benjamini
Proteasome 31 1.7 5.0 1.6E-15 2.6E-13
Endocytosis 52 2.9 2.1 2.5E-7 2.1E-5
Aminoacyl-tRNA biosynthesis 19 1.0 3.8 3.2E-7 1.8E-5
Axon guidance 36 2.0 2.3 2.7E-6 1.1E-4
Ubiquitin mediated proteolysis 35 1.9 2.2 6.3E-6 2.1E-4
Regulation of actin cytoskeleton 46 2.5 1.8 1.2E-4 3.2E-3
Fc gamma R-mediated phagocytosis
a 24 1.3 2.2 3.3E-4 7.8E-3
Tight junction
b 31 1.7 1.9 4.7E-4 9.8E-3
Pyruvate metabolism 14 0.8 2.9 5.6E-4 1.0E-2
Citrate cycle (TCA cycle) 12 0.7 3.2 5.9E-4 9.8E-3
Terpenoid backbone biosynthesis 8 0.4 4.6 6.9E-4 1.0E-2
Long-term potentiation 19 1.0 2.3 1.0E-3 1.4E-2
Insulin signaling pathway
c 30 1.7 1.8 1.3E-3 1.7E-2
Pentose phosphate pathway 10 0.6 3.3 1.6E-3 1.8E-2
Amino sugar and nucleotide sugar metabolism 14 0.8 2.6 1.6E-3 1.7E-2
Purine metabolism 33 1.8 1.7 2.1E-3 2.1E-2
Glutathione metabolism 15 0.8 2.4 2.4E-3 2.3E-2
DNA replication 12 0.7 2.8 2.5E-3 2.3E-2
Glycolysis/gluconeogenesis 21 1.2 2.0 2.7E-3 2.3E-2
ErbB signaling pathway
d 21 1.2 2.0 3.1E-3 2.6E-2
(20 pathways identified with the highest statistical significance).
a–d: Pathways not included for further consideration because they share elements with several other pathways, and, especially, because their key identifying proteins
[Fcc receptor (a); claudins, occludins (b); insulin receptor (c); ErbB (d)] were not detected.
doi:10.1371/journal.pone.0031858.t002
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PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31858The presence of ‘‘nuclear’’ proteins in the growth cone
proteome deserves particular scrutiny. Figure 14 shows hippo-
campal pyramidal neurons and their axonal growth cones labeled
with antibodies to an importin family protein, karyopherin a2
(Kpna2), to Pcna and to Mcm7, a DNA prereplication complex
component. While the presence in the axonal growth cone of
importins is consistent with recent reports [26,27,28], that of
Mcm7 and Pcna is surprising but consistent with the proteomic
data.
Discussion
The axonal growth cone plays a critical role in the development
of neuronal circuits so that its protein components and functions
are of great interest. The goal of the present study was to generate
extensive and robust data on the functional groups of proteins
present in the axonal growth cone, at a time when the developing
neuron is polarized and the growth cone widely separated from its
perikaryon.
1. Data Validation
The starting material for the proteomic analysis was GCPs
isolated from fetal rat brain, the preparation also used by Nozumi
et al. [9]. Consistent with Nozumi’s data, we found enrichment in
the proteome of axonal growth cone ‘‘marker’’ proteins (such as
Gap43) and abundance of proteins involved in well-established
growth cone functions, such as vesicular traffic and cytoskeletal
remodeling (see also [29]). We also observed a lack (after
background subtraction) of proteins known to be absent from
growth cones, such as serum proteins, glial markers and certain
nuclear proteins [e.g., histones (H1, H2A, H2B, H3 and H4),
Apex1 nuclease; but see below]. Several axonal guidance receptors
(Ephb2, plexins, Robo2; see Fig. 6A), which are critical for growth
cone function, also were evident in our analyses. Of the 17
Figure 6. Proteins with the most abundant spectral counts under the following GO Terms: (A) ‘‘Growth Cone’’ (cytoplasmic
component, CC) and ‘‘Axon Guidance’’ (biological process, BP); (B) ‘‘Actin Cytoskeletal Organization’’ (BP) and ‘‘Regulation of
Microtubule Polymerization/Depolymerization’’ (BP); (C) ‘‘Vesicle Targeting/Docking’’ (BP) and ‘‘Vesicle Fusion’’ (BP); and (D)
‘‘Hexose Catabolic Process’’ (BP) and ‘‘ATP Biosynthetic Process’’ (BP). Note that scales are different for each panel.
doi:10.1371/journal.pone.0031858.g006
Figure 5. KEGG pathways in axonal growth cones. The five relevant KEGG pathway categories and their subcategories (enriched subcategories
are shaded) are listed on the left. The numbers following each subcategory title indicate the number of pathways detected in GCPs/total number of
identified pathways in mammals. Bars indicate the average enrichment factor for the subcategory (green), the enrichment factor for each pathway
(blue), and the number of protein species of the pathway detected in GCPs (ochre). P values (,0.05) are shown on the right.
doi:10.1371/journal.pone.0031858.g005
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[9], 14 were detected in our analysis as well. However, they
detected only 12 of our 43 most abundant identifying spectra
($400 spectra each). Among those not seen by them were Actg1
(actin, cytoplasmic 2 or c-actin), Dpysl2 (dihydropyriminidase-
related protein 2) and Tubb2b (tubulin beta-2B chain) (.2000
spectra each in our analysis). Some of the discrepancies may stem
from differences in protein isoforms: We detected Tubb2b and
Myh10 (myosin-10) whereas they identified Tubb2a (tubulin beta-
2A chain) and Myh11 (myosin 11). Overall, however, there is
substantial agreement except that our analysis revealed about
twice the number of proteins reported earlier [9].
Nuclear proteins. It is evident that the nucleus is not a
growth cone component. Indeed, we did not detect Apex1 and
Rtf1 and identified only one of the core histones, Hist3h2ba, in our
net preparation. Yet, two karyopherins/importins (Kpnb1 and
Ipo5) were among the 43 most abundant proteins ($400 spectra
each in growth cones). The proteomic result was confirmed for
Kpna2 by immunofluorescence (Fig. 14) and is consistent with
reports showing their function in retrograde transport of signaling
molecules from the axonal growth cone to the nucleus [26,27].
More surprising was the detection of Mcm family DNA helicase
subunits, Pcna and Hist3h2ba in the GCP preparation. How-
ever, Zivraj et al. [30] reported the presence of Mcm2, 6 and
7 transcripts in the mouse growth cone. Furthermore, immu-
nofluorescence of intact neurons in culture (Fig. 14) clearly shows
Pcna and Mcm7 in the axonal growth cone, a finding that may be
related to the cytoplasmic occurrence of these proteins in other
cells [18,19]. We do not know whether these proteins, as well as
Hist3h2ba, reached the growth cone without a functional role,
whether they perform a function related to that in the nucleus
(e.g., in conjunction with RNA), or whether they play an
altogether different, unknown role as ‘‘moonlighting’’ proteins in
the axonal growth cone [31].
Figure 7. Frequencies of the most abundant spectra identifying proteins under the following GO Terms: (A) ‘‘Translation’’ and
‘‘Translational Initiation’’ (biological process, BP); (B) ‘‘ER to Golgi Vesicle-Mediated Transport’’ (BP)/‘‘Golgi Vesicle Budding’’ (BP);
(C) ‘‘Protein Folding’’ (BP); and (D) ‘‘Ubiquitin Protein Ligase Activity’’ (BP); ‘‘Proteasomal Protein Catabolic Process (BP)/
‘‘Proteasome Complex’’ (cellular component, CC).
doi:10.1371/journal.pone.0031858.g007
Figure 8. Frequencies of the most abundant spectra identifying
proteins under the following GO Terms: ‘‘Cellular Response to
Oxidative Stress’’ (BP) and ‘‘Terpenoid/Sterol Biosynthetic
Processes’’ (BP).
doi:10.1371/journal.pone.0031858.g008
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each protein not previously shown to be in axonal growth cones
should be immunolocalized before further conclusions can be
drawn. The data in the Nozumi et al. [9] study suggest the same
functional annotation groups we have identified, but the
discrepancies show that sample amounts and preparation, as well
as instrumentation, can substantially affect the outcome of a
proteomic analysis.
2. Proteins Characteristic of Axonal Growth Cones
Our bioinformatics studies were performed and presented so as
to minimize bias, using functional annotation clustering and
KEGG pathway analyses as tools (DAVID). In addition, we
present the numbers of identifying spectra as a semi-quantitative
measure of protein abundance. Interpretation of these numbers
requires caution because they are not dependent on protein
abundance alone. Other factors influencing them are: protein
solubility during sample preparation; protein size and cleavage
efficiency; ionization efficiency of peptides. Furthermore, we used
exclusion filters when sequencing peptides to optimize the number
of unique peptides observed so that the most abundant proteins
were undersampled. Nevertheless, the numbers of identifying
spectra can provide a rough estimate of protein abundance.
As a motile structure distant from the perikaryon the axonal
growth cone must have its own energy supply, and it is known to
contain mitochondria. Not surprisingly, therefore, we detected 35
mitochondrial proteins, and the GO Terms ‘‘Hexose catabolic
process’’ and ‘‘ATP biosynthetic process’’ are well represented by
abundant spectra (Fig. 6; see also Figs. 2 and 4).
In view of the importance of vesicular transport to the growth
cone, growth and dynamics of the microtubule cytoskeleton of the
axon, and constant remodeling of the actin cytoskeleton during
growth cone advance, we expected and found an abundance of
proteins of the microtubule and actin cytoskeletons, as well as
those involved in their regulation. Together with the collapsin
response mediator proteins (CRMPs), which participate in growth
cone steering and microtubule regulation [17], the most abundant
species of these proteins comprise over 21% of all spectra detected
(Fig. 2). Vesicle-based traffic (vesicle formation, endocytosis,
transport, docking and fusion) is essential for plasmalemmal
expansion and transfer of proteins from one cellular compartment
to another. Proteins involved in traffic are highly prominent in
every type of analysis conducted. For example, Vcp and Cltc are
among the most frequent spectra detected (&500). GO Terms
describing vesicle traffic are highly enriched in all of the analyses
(Figs. 3, 4, 6). The kinesin and dynactin complexes are enriched
Figure 9. Abundance of non-typifying proteins in fetal brain fractions including GCPs, as determined by Western blot. A shows the
relative abundance in fetal brain homogenate (H), low-speed supernatant (LSS) and GCPs (40 mg protein/lane) of six non-typifying proteins, a cytosolic
marker (Ldh) and a growth cone marker (Gap43). Hsp90 is Hsp90ab1. B illustrates the presence of immunoreactivity of six additional proteins in fetal
brain LSS and GCPs (equal amounts of protein loaded). C shows the quantitative analysis of the data in A. Net fluorescence intensities of the bands
shown in A were normalized to H for each experiment and then averaged (experiments done in triplicate). The resulting relative density units shown
equal the fold increase in immunoreactivity relative to H (means 6 s.e.m.). p values are shown where GCP enrichment over H was significant.
doi:10.1371/journal.pone.0031858.g009
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amount to .8% of all proteins identified.
3. Non-Typifying Proteins in Axonal Growth Cones
The question of whether the axonal growth cone was capable of
synthesizing proteins was a hotly debated issue not that long ago
[32]. Yet, convincing evidence for protein synthesis in the axon
and its growth cone has emerged over the past ten years
[33,34,35,36,37,38,39,40,41,42]. Some of the proteins synthesized
in the axonal growth cone are known to be membrane proteins
and may be glycosylated [35,43]. However, our knowledge of
posttranslational processing in the growth cone is limited [44].
Proteasomal protein degradation in the axonal growth cone has
been reported and linked to axonal differentiation, pathfinding
and regeneration [33,45,46,47]. Our proteomic analysis confirms
and extends these insights by demonstrating the presence of a very
large number of proteins for protein synthesis, folding, processing
and degradation. These issues are addressed below in greater
detail.
Translation and Protein Folding. All of our analyses show
strong representation, in terms of protein species diversity as well
as numbers of identifying spectra detected, of the biological
Figure 10. Hippocampal pyramidal neurons and/or their axonal growth cones labeled with antibodies to proteins involved in
protein synthesis (top row). The antibody specificities are indicated above. Dual-fluorescence images including labeling for filamentous actin are
shown in the bottom row. pk, neuronal perikaryon; large arrows, axonal growth cones; small arrows, reticular structures.
doi:10.1371/journal.pone.0031858.g010
Figure 11. Hippocampal pyramidal neurons and their axonal growth cones labeled with antibodies to proteins involved in protein
folding (top row). The antibody specificities are indicated above. Additional filamentous-actin label is shown in the bottom row. pk, neuronal
perikaryon; large arrows, axonal growth cones. Small arrows indicate: left, reticular structures (Pdia6); right, edge labeling (Hsp90ab1).
doi:10.1371/journal.pone.0031858.g011
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factors are among the 43 most abundant species detected in axonal
growth cones (together accounting for 1.5% of spectra; Fig. 2).
Functional annotation analysis for cellular components reveals 3-
to nearly 10-fold enrichment of proteins involved in translational
initiation, elongation, ER, Golgi-associated vesicle, and
chaperonin-containing T-complex (Fig. 3). Annotation clusters
(biological process) for tRNA aminoacylation and translation
Figure 12. Hippocampal pyramidal neurons and/or their axonal growth cones labeled with antibodies to Golgi proteins (top row).
The antibody specificities are indicated above. cis/medial/trans, known Golgi location of the antigens. pk, neuronal perikaryon; large arrow, axonal
growth cone; small arrows, reticular structures.
doi:10.1371/journal.pone.0031858.g012
Figure 13. Hippocampal pyramidal neurons and/or their axonal growth cones labeled with antibodies to proteins involved in
proteasomal degradation (top row). The antibody specificities are indicated above. Additional filamentous-actin label is shown in the bottom
row. pk, neuronal perikaryon; large arrow, axonal growth cone; small arrow, Psma-positive, large puncta.
doi:10.1371/journal.pone.0031858.g013
Proteome of the Axonal Growth Cone
PLoS ONE | www.plosone.org 14 February 2012 | Volume 7 | Issue 2 | e31858(cluster 7 and group B in Fig. 4) and KEGG Pathway analysis
(Fig. 5; 2.2) show high enrichment of proteins involved in
translation, including 35 ribosomal proteins (see also Fig. 7A).
This was confirmed by immunolocalization in axonal growth
cones in culture. The elongation factor Eef1a1 was concentrated
primarily in the proximal growth cone, together with Rps3 and the
rough-ER membrane protein Rpn1. Rps3 and Rpn1 are of
particular interest because their labeling patterns are distinctly
reticular, compatible with that of rough ER (Fig. 10). A similar
pattern was observed with the ER lumen chaperone Pdia6
(Fig. 11), while the cytosolic Hsp90ab1 was diffusely distributed.
Thus, immunofluorescence analysis confirms the proteomic data
and identifies a rough ER-like reticular compartment in axonal
growth cones.
Our analyses also reveal that 11 of the 43 most commonly
detected spectra identify proteins involved in folding, such as heat
shock proteins and chaperonins (Fig. 2). Together these 11
proteins represent 6.3% of all protein species identified (see also
Fig. 7C). It is reasonable to assume that these chaperones and
chaperonins are essential for folding and maintaining locally
synthesized proteins (see also [38,44]). Moreover, remodeling may
serve to reactivate defunct proteins and to disassemble normal or
abnormal protein aggregates [48,49]. An increased need for
protein remodeling may explain the abundance of the relevant
proteins in the remote axonal growth cone.
Posttranslational Processing. At least one of the proteins
known to be translated in the axonal growth cone, the kappa
opioid receptor [43], has two potential N-glycosylation sites
suggesting that a Golgi-like structure may be present in the axonal
growth cone. Indeed, [44] presented evidence for rough ER- and
Golgi-like compartments in the axon. Our functional annotation
analysis (cellular component or biological process) showed high
growth cone enrichment of proteins involved in ER-Golgi
intermediate compartment, Golgi-associated vesicle (Fig. 3),
Golgi vesicle budding, Golgi vesicle transport, and ER-Golgi
vesicle-mediated transport (Fig. 4; Group A). Valosin-containing
protein (Vcp), one of the most common axonal growth cone
proteins (about 1200 spectra detected; Figs. 2 and 7B), seems to
operate primarily in ER-to-Golgi vesicle traffic, but it may be
involved in the regulation of protein homeostasis as well [50].
Immunolocalization of 3 Golgi ‘‘marker’’ proteins, Man2a1 (cis/
medial Golgi), Golph3 (trans Golgi), and Tgoln1 (trans Golgi)
showed that all three were readily detected in axonal growth
cones. Man2a1 and, especially Golph3 and Tgoln1 were present
in a distinctive reticular network. While there was no evidence for
stacks of membrane sacs as seen in the classic Golgi apparatus, our
data indicate the presence of a rather elaborate specialized
compartment with Golgi-like functions in the axonal growth cone.
Farnesylation and geranylation are posttranslational protein
modifications best known for GTP-binding proteins and depend
on terpenoid and sterol biosynthetic processes. Interestingly, these
processes are among the most highly enriched in the axonal
growth cone (Table 2, Figs. 5 and 7). As farnesylation and
geranylation seem to be permanent [51] this finding suggests that
at least some of the proteins that carry such posttranslational
modifications are synthesized de novo in the growth cone. This is
consistent with the finding of mRNAs encoding small G proteins
[30] and their translation products, and of Rab geranylgeranyl-
transferases (present study) in the growth cone.
Growth Cone Proteome versus Transcriptome. The
recently published transcriptome of axonal growth cones [30]
(see also that of axons [52]) lists over 400 identified transcripts in
mouse and Xenopus growth cones. Functional classification of
messages suggests that the axon is equipped to synthesize a highly
diverse range of proteins. Even though the systems used for the
two studies are not identical (growth cones laser-capture
microdissected from cultured retinal ganglion cells versus those
isolated from fetal brain; different species) the comparison of
mouse transcriptome and rat proteome is of interest. Overall, the
functional categories of transcripts and proteins identified in the
axonal growth cones overlap extensively. For a more detailed
comparison of transcriptome and proteome we analyzed two
protein families (Rab and Kif) and the subunits of a large protein
complex, the proteasome (Table 3). For the 26 Rabs, 10 Kifs and
37 Psms detected in the proteome, Zivraj et al. [30] reported 4, 5
and 16 (or about 15%, 50% and 43%) corresponding messages,
respectively. Thus, there is overlap, but the reported transcriptome
of the axonal growth cone lacked the messages encoding a
significant number of protein species, suggesting that these are
synthesized in the perikaryon only. For Rabs, Kifs and Psms
protein prevalence, as judged from the abundance of identifying
spectra detected (Table 3), did not correlate with the presence or
absence of corresponding transcripts (and presumably local
translation) in the growth cone (see, e.g., Rab3b vs. Rab11b;
Kif5c vs. Kif22; Psmd1 vs. Psmf1; Psmd12 vs. Psme4).
Furthermore, both ‘‘structural’’ (Psma and Psmb; italicized in
Table 3) and regulatory (Psmc – Psmf) subunits of the proteasome
may or may not be represented in the transcriptome. Although we
have only limited information about which messages are translated
in the axon and its growth cone the comparison of proteome and
transcriptome provides an important tool for hypothesis
generation.
Protein Degradation. The most abundant assigned spectra
in our analysis include 3 proteins involved in ubiquitination/
proteasome function (Fig. 2). Functional annotation (Cellular
Figure 14. Hippocampal pyramidal neurons and their axonal
growth cones labeled with antibodies to proteins involved in
functions of the nucleus (top row). The antibody specificities are
indicated above. Additional filamentous-actin label is shown in the
bottom row. Large arrows, axonal growth cones.
doi:10.1371/journal.pone.0031858.g014
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signalosome complexes (Fig. 3), and the third-most enriched
annotation cluster (biological process) comprises functions
associated with ubiquitin-dependent and/or proteasome-
dependent protein catabolism (Fig. 4; see also Fig. 7D). KEGG
analysis shows proteasome function as the most highly enriched
pathway in the growth cone. Localization by immunofluorescence
confirms these findings and shows a pattern of small puncta or
Table 3. Proteome of the Growth Cone versus Transcriptome of the Growing Axon.
PROTEIN ISOFORMS (Rab; Kif) SUBUNITS OF A LARGE PROTEIN COMPLEX
Rab Proteome # spectra* Transcriptome [30] Psm** Proteome # spectra* Transcriptome [30]
1a 44 # Psma1 57 X
1b 62 X Psma2 57 #
2a 101 X Psma3(I) 24 X
2b 17 # Psma4 67 #
3a 56 # Psma5 57 #
3b 5 # Psma6 72 X
3c 58 # Psma7 53 #
4a 9 # Psmb1 70 #
4b 11 # Psmb2 38 #
5a 52 # Psmb3 47 X
5b 41 # Psmb4 33 X
5c 113 # Psmb5 73 #
6a 63 # Psmb6 25 X
6b 30 X Psmb7 50 X
7a 92 # Psmb8 0X
8a 5 # Psmc1 84 #
9a 5 # Psmc2 55 X
9b 8 # Psmc3 119 #
10 83 # Psmc4 103 X
11b 163 # Psmc5 105 #
14 132 X Psmc6 82 X
21 27 # Psmd1 399 #
23 14 # Psmd2 284 #
31 20 # Psmd3 122 X
33a 11 # Psmd4 102 #
35 30 # Psmd5 47 #
Entries 26 4 Psmd6 94 X
Kif Proteome # spectra* Transcriptome [30] Psmd7 108 #
1a 76 X Psmd10 6 #
1b 9 # Psmd11 118 X
2 28 # Psmd12 139 X
3a 20 # Psmd13 150 #
3b 7 # Psmd14 139 #
5a 6 # Pmse1 21 #
5b 80 X Psme2 148 #
5c 222 X Psme3 42 #
21a 32 # Psme4 28 X
21b 66 # Psmf1 3 #
22 0X -- -
c2 0X Entries 37 16
Entries 10 5 **) Italicized symbols
indicate structural
proteasome subunits
*) Net spectral numbers.
x) mRNA detected in mouse growth cones.
doi:10.1371/journal.pone.0031858.t003
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proteasome a subunits. The patterns for the regulatory
components, Psme3 and Uba1, are similar but, strikingly, reach
into fine filopodia. In other words, our proteomic results augment
the concept that axonal growth cones contain elaborate machinery
for protein degradation [33,45,46,47]. The need for local protein
degradation is perhaps not so surprising once we consider the large
amount of protein transported down the axon. However,
ubiquitin- and proteasome-dependent protein catabolism has
been implicated in highly selective degradation of proteins that
affect the growth cone response during midline crossing and others
involved in synaptogenesis and plasticity [33,45,46,47,53,54].
Thus, such controlled and selective protein breakdown seems to
play a major role in the regulation of many growth cone-specific
functions.
4. Overall Conclusions
Our proteomic analysis of axonal growth cones isolated from
fetal rat forebrain has identified .1800 proteins with a high level
of confidence ($99%). Many of these play roles in typical, well-
understood growth cone functions and, thus, were expected. They
include, first and foremost, actin and tubulin and regulators of the
respective cytoskeletal structures, as well as proteins involved in
vesicular traffic. Less abundant but prominent in their variety are
axonal guidance receptors, adhesion molecules, and regulatory
proteins, such as GTP-binding proteins. The data provided here
should be a useful resource for further studies on growth cone
functions, either new or well-established.
Perhaps of greater importance is the identification of a large
number of proteins that define, by annotation and KEGG
pathway analyses, machinery for protein synthesis, folding,
posttranslational processing, complex assembly and regulated
degradation in the axonal growth cone. These findings confirm
and amplify previous studies that located these processes at the
axonal growth cone [33,38,40,41,44]. However, (i) the prepon-
derance of the relevant protein species, relative to random gene
expression and based on the high numbers of identifying spectra
detected, and (ii) the quantitative enrichment of a number of
these proteins in the axonal growth cone was not expected.
Furthermore, we describe for the first time (iii) discrete reticular
structures with rough-ER and Golgi apparatus functions in the
axonal growth cone. Especially striking are the amounts and
variety of proteins involved in protein folding and catabolism.
From an overall viewpoint, our study confirms and extends the
concept that the axonal growth cone is much more broadly
equipped with cellular functions than originally assumed and,




Animal use: Pregnant Sprague-Dawley rats were purchased
from Harlan Laboratories (Indianapolis, IN) and kept for a few
days in the local animal facility accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care (Animal
Welfare Assurance Number PHS A3269-01). The animals were
handled in strict compliance with Protocol #21708(01)1B,
approved by the University of Colorado Health Sciences Center
Animal Care and Use Committee and with the Guidelines for the
Care and Use of Laboratory Animals of the National Institutes of
Health. For tissue collection rats were sacrificed under terminal
isoflurane anesthesia, and every effort was made to minimize
suffering.
Materials
Antibody specificities, hosts and sources: Golph3 and Tgoln1
(rabbit polyclonal) were generous gifts of Dr. C. Wu, then at
University of Colorado School of Medicine. Kpna2 (chicken
polyclonal), Man2a1 (mouse monoclonal), Mcm7 (mouse mono-
clonal), Pcna (rabbit polyclonal), Pdia6 (chicken polyclonal), and
Uba1 (rabbit polyclonal) from Abcam (Cambridge, MA). Rpn1
(rabbit polyclonal) from Abgent (San Diego, CA). Hsp90ab1
(rabbit polyclonal) from Affinity Bioreagents, Inc. (Golden, CO).
Rps3 (rabbit polyclonal) from Cell Signaling Technologies, Inc.
(Beverly, MA). Psme3 (rabbit polyclonal) from Enzo Life Sciences
(Farmingdale, NY). Eef1a1 (mouse monoclonal) and Psma (anti-a
1, 2, 3, 5, 6, 7; mouse monoclonal) from EMD Millipore (Billerica,
MA). Cell culture supplies were from Invitrogen/Life Technolo-
gies (Carlsbad, CA). Other chemicals, unless stated otherwise,
were from Sigma-Aldrich (St. Louis, MO) or Thermo Fisher
Scientific (Pittsburgh, PA) and of the highest quality available.
Growth cone isolation
GCPs were prepared as described previously [6,7]. Briefly,
whole brains from gestation day-18 fetal rats were homogenized in
0.32 M sucrose containing 1 mM MgCl2, 2 mM TES buffer
(pH 7.3), and 2 mM aprotinin. Low-speed (16606g, 15 min)
supernatant (LSS) of the homogenate was layered onto a
discontinuous density gradient (0.83 and 2.66 M sucrose contain-
ing MgCl2 and TES buffer) and spun to equilibrium at 242,0006g
at 4uC for 40 min in a vertical rotor (VTi50, Beckman). The GCP
fraction at the 0.32/0.83 M-sucrose interface and a sample of the
gradient’s supernatant (0.32 M sucrose) were collected.
Plating of GCPs in laminin-coated wells
24-well tissue culture plates werecoated with 20 mg/mlof laminin
in Hank’s balanced salt solution for 3 h and rinsed three times
with phosphate-buffered saline (PBS) supplemented with 0.9 mM
CaCl2 and 0.5 mM MgCl2 (PBS-Ca
+2/Mg
2+). Wells were blocked
with 5% non-fat dry milk in PBS for 30 minutes and rinsed again.
GCPs were gradually diluted with 26 modified Krebs buffer
(0.05 M sucrose, 0.1 M NaCl, 5 mM KCl, 22 mM HEPES,
10 mM glucose, 1.2 mM NaH2PO4, 1.2 mM MgCl2,2 m M
CaCl2, pH 7.3) and incubated at 37uC for 10 min. After
incubation equal aliquots of the GCP suspension were transferred
into the 24-well culture dish, spun at 4,000 rpm for 15 min and
incubated at 37uC for 30 min. Under these conditions the resealed
and viable GCPs attached to the laminin-coated plastic.
Attached GCPs were extracted in two steps: (1) Brij Buffer
(5 mM MgCl2, 1 mM CaCl2, 1% Brij 98 in PBS) was added for
incubation at 37uC for 20 min, followed by 40 min at 4uC. The
supernatant was collected as the Brij-soluble fraction. (2)
Remaining adherent structures were rinsed 2 times with PBS-
Ca
+2/Mg
2+ and lysed in 1% SDS. A chloroform/methanol (C/M)
precipitation [55] was performed with all samples, and the pellets
were resuspended in 5% SDS and used for electrophoresis.
Controls: (a) Laminin-coated wells without GCPs. These were
extracted with 1% SDS and the supernatant C/M-precipitated.
The pellets were solubilized in 5% SDS. (b) Aliquot of the
gradient’s supernatant (clear; containing soluble proteins of the
brain homogenate). This sample was C/M precipitated and
solubilized in 5% SDS.
Gel electrophoresis and sample preparation for mass
spectrometry
Protein samples (50–60 mg/lane), alongside with dual-colored
Precision Plus Protein
TM standards (Bio-Rad Laboratories, Inc.,
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electrophoresis using NuPAGE Novex Bis-Tris gradient gels
(Invitrogen, Carlsbad, CA). After separation, the gel was stained
with Coomassie Blue (Invitrogen). Each lane of the gel was cut into
25 equal-sized pieces, which resulted in a range of 30–400 (average
about 80) proteins per slice. Proteins in the gel were digested as
follows. Bands were destained in 200 ml of 25 mM ammonium
bicarbonate in 50% v/v acetonitrile (ACN) for 15 min and then
incubated in 200 ml of 100% ACN for 15 min at room
temperature. After addition of dithiothreitol (DTT) to a final
concentration of 10 mM, slices were incubated at 65uC for 30 min
to reduce the disulfide bonds. The reduced cysteines were
alkylated with the addition of iodoacetamide (IAA) at a final
concentration of 20 mM (30 min at room temperature in the
dark). The IAA was removed, and washes were performed with
200 ml of distilled water followed by addition of 100 ml of ACN.
ACN (i.e., all liquid) was removed in a vacuum concentrator to
allow complete gel rehydration thereafter. We added 50 mlo f
0.01 mg/ml trypsin in 25 mM ammonium bicarbonate (,pH 7.4)
to each sample and allowed the gel pieces to rehydrate at 4uC for
30 min, before incubation at 37uC overnight. The tryptic mixtures
were acidified with formic acid (FA) up to a final concentration of
1%. Peptides were extracted three times from the gel slices using
50% ACN and 1% FA, concentrated by SpeedVac to a desired
volume (,18 ml), and subjected to LC-MS/MS analysis. If
necessary, they were stored at 220uC.
Liquid Chromatography–Tandem Mass Spectrometry
Nano-flow reverse phase LC-MS/MS was performed using a
capillary HPLC system (Agilent 1200, Palo Alto, CA) coupled via
an electrospray ionization source to a linear ion trap hybrid ion
cyclotron resonance mass spectrometer (LTQ-FT Ultra, Thermo-
Fisher; San Jose, CA).
Eight microliters of the tryptic peptides were pre-concentrated
and desalted on a C18 trap column ZORBAX 300SB-C18,( 5mm
i.d. 65 mm, Agilent Technologies, Santa Clara, CA) with 5%
ACN, 0.1% FA at a flow rate of 15 ml/min for 5 minutes. The
separation of the tryptic peptides was performed at a flow rate of
380 nl/min on a C18 reverse phase column (75 mmI D 6360 mm
OD6100 mm length) packed in-house with 4-mm, 100-A ˚ pore size
C18 reversed-phase stationary phase (Synergy, Phenomenex,
Torrance, CA), kept at a constant 40uC using an in-house built
column heater. The mobile phases consisted of 5% ACN with
0.1% FA (A) and 95% ACN with 0.1% FA (B), respectively. A 90-
min linear gradient from 5 to 50% B was typically used. Data
acquisition was performed using the instrument-supplied Xcalibur
(version 2.0.6) software. The LC runs were monitored in positive
ion mode by sequentially recording survey MS scans (m/z 400–
2000) in the ion cyclotron resonance cell, while three MS/MS
were obtained in the ion trap via collision-induced dissociation for
the most intense ions. Once ions were selected for MS/MS they
were reacquired after 30 seconds and then excluded for
90 seconds.
Database searching, protein identification
MS and MS/MS spectra were de-isotoped, centroided from
raw data files and converted into ‘‘mgf’’ files using an in-house
script. Mascot (version 2.2; Matrix Science Inc., London, UK) was
used to perform database searches against rat sequences in the
SwissProt database using the extracted data. Parent MS tolerance
was set at 610 ppm with MS/MS tolerance set at 60.6 Da.
Trypsin specificity was used allowing for 1 missed cleavage. The
modifications of methionine oxidation, protein N-terminal acety-
lation, and peptide N-terminal pyroglutamic acid formation were
allowed for, and cysteine carbamidomethylation was set as a fixed
modification.
Scaffold version 2 (Proteome Software, Portland, OR, USA) was
used to validate and compare MS/MS based peptide and protein
identifications. All ‘‘.DAT’’ files (from Mascot) for the 25 gel bands
were loaded together as one ‘‘biological sample’’ within Scaffold.
Peptide identifications were accepted if they could be established
at greater than 95.0% probability as specified by the Peptide
Prophet algorithm. Protein identifications were accepted if they
could be established at greater than 99.0% probability and
contained at least two identified unique peptides. Proteins are
referred to by their official encoding gene names (Entrez Gene;
NCBI, U.S. National Library of Medicine). A list of abbreviations
and protein names is provided in Table S1.
Data analysis
Protein identifications and number of identifying spectra for
each fraction were exported from Scaffold software. The following
parameters were used: 99% confidence limit for protein
identification; minimum number of peptides, 2; minimum
confidence level for peptide identification, 95%. For the purposes
of the present overall growth cone analysis, data for Brij-soluble
and Brij-insoluble fractions were combined. ‘‘Background’’, i.e.,
potentially contaminating polypeptides from the laminin plating
matrix and the gradient supernatant, were subtracted as explained
and illustrated in Results. The net growth cone (GCP) data were
used for further analysis. The raw data are shown in Table S2.
For annotation analysis, gi protein accession numbers were
uploaded into the DAVID (Database for Annotation, Visualiza-
tion and Integrated Discovery) informatics tool (DAVID Bioinfor-
matics Resources 6.7; [10,11,12]). For GO Term (Gene Ontology)
analysis we studied the ‘‘Cellular Component’’ and ‘‘Biological
Process’’ categories using the GO FAT default settings. At these
settings the program uses a subset of GO Terms depleted of the
broadest terms (primarily from the top 5 levels of the tree) to avoid
overshadowing of the more specific terms (term specificity defined
on the basis of the number of child terms in the hierarchy; see
DAVID website). Use of GO FAT generated more informative
results than that of any specific GO Term level. For functional
annotation searches we set the following parameters: ‘‘Cellular
Component’’, threshold count 5, EASE 0.1 (resulting in 171 chart
records); ‘‘Biological Process’’, threshold count 5, EASE 0.1
(resulting in 481 chart records); for functional annotation clusters
(‘‘Biological Process’’), medium stringency (resulting in 194
clusters). For KEGG pathway searches the parameters were:
Threshold count 5 (resulting in 54 records).
Enrichment values (GO Terms), enrichment scores (annotation
clusters), and statistical determinants (p values and Benjamini
coefficients) are those calculated by DAVID software. The
Benjamini coefficients are Benjamini-Hochberg corrected p
values. They are adjusted for multiple comparisons to lower the
family-wise false discovery rate and, thus, are more conservative
than Fisher Exact p values.
Western Blots
Fetal brain homogenate (H), LSS and pelleted GCPs (equal
amounts of protein loaded) were analyzed by SDS gel electro-
phoresis as described above. Resolved proteins were transferred
electrophoretically onto Immobilon P (EMD Millipore Co.,
Billerica, MA) membranes. Membranes quenched in Tris-buffered
saline with 5% non-fat evaporated milk and 0.1% Tween-20 were
probed with primary and fluorescent secondary antibodies (Alexa
Fluor 647, 555 or 488; Life Technologies/Invitrogen Co.,
Carlsbad, CA) and analyzed with a Typhoon 9400 multi-mode
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in triplicate. After background subtraction, densities of antigen
bands (determined with Imagequant software) were normalized to
H levels and values averaged. Significance of H versus GCP levels
of immunoreactivity was determined using Student’s t test. To
assess the specificity of the other antibodies used for immunoflu-
orescence we followed the same electrophoresis and Western blot
protocols.
Immunofluorescence analysis of neurons in culture
Hippocampi from 18-day gestation Sprague-Dawley rat fetus
were cut into explants or dissociated with trypsin. Explants or
dissociated hippocampal pyramidal neurons were cultured on
laminin-coated coverslips (Assistant brand) in B27 neurobasal
medium supplemented with 10% v/v fetal bovine serum for 1–
3 hours and then in serum-free B27 medium. After 1–2 days
incubation at 37uC, 5% CO2 neurons were fully polarized and
processed for indirect immunofluorescence.
Cultures were fixed using slow infusion of fixative [4% w/v
paraformaldehyde, 0.1 M phosphate buffer (pH 7.4), 120 mM
glucose, 0.4 mM CaCl2] as developed for electron microscopic
analysis [56]. Cultures were rinsed (36) with PBS containing
1 mM glycine, permeabilized with blocking buffer (PBS, 1% w/v
bovine serum albumin) plus 1% (v/v) Brij
TM 98 detergent for
2 min at room temperature, and washed (36) with blocking buffer.
Samples were labeled with primary antibody in blocking buffer for
1 hour at room temperature and washed 36with blocking buffer.
This process was repeated with Alexa Fluor 488-(green) or 594-
(red) conjugated secondary antibodies and with red or green
fluorescent phalloidin to label filamentous actin (Molecular
Probes, Eugene, OR). These coverslips were mounted on slides
using a polyvinyl alcohol/glycerol anti-fade medium. Samples
were analyzed with a Zeiss Axiovert 200 M microscope operated
by Metamorph Software (Molecular Dynamics, Sunnyvale, CA)
and equipped with Zeiss lenses, epifluorescence and total internal
reflection fluorescence (TIRF) optics, and a Cook Sensicam digital
camera.
Supporting Information
Table S1 This table provides full protein names for the
gene symbols used throughout the text.
(PDF)
Table S2 Proteins identified in isolated axonal growth
cones, together with their gi accession numbers, molec-
ular weights (Mol W) and numbers of identifying spectra
detected in the gross GCP (isolated growth cones)
preparation, background (Bkgd; composed of control
and laminin coat of wells; see narrative), and net GCP
preparation (values shown as$0). Note that, in a few cases,
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